EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advances in Endometrial Cancer Prevention, Early Diagnosis and Treatment

Holly Baker-Rand, Sarah J Kitson iD

Cancers · 01.03.2024 · 16 (5) · 1028

DOI: 10.3390/cancers16051028 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 01.03.2024. Verfasst von Holly Baker-Rand und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK. Die Arbeit wurde bisher 95-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Cancer Grand Challenges.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometrial cancer is the sixth commonest cancer in women worldwide, with over 417,000 diagnoses in 2020. The disease incidence has increased by 132% over the last 30 years and is set to continue to rise in response to an ageing population and increasing global rates of obesity and diabetes. A greater understanding of the mechanisms driving endometrial carcinogenesis has led to the identification of potential strategies for primary disease prevention, although prospective evaluation of their efficacy within clinical trials is still awaited. The early diagnosis of endometrial cancer is associated with improved survival, but has historically relied on invasive endometrial sampling. New, minimally invasive tests using protein and DNA biomarkers and cytology have the potential to transform diagnostic pathways and to allow for the surveillance of high-risk populations. The molecular classification of endometrial cancers has been shown to not only have a prognostic impact, but also to have therapeutic value and is increasingly used to guide adjuvant treatment decisions. Advanced and recurrent disease management has also been revolutionised by increasing the use of debulking surgery and targeted treatments, particularly immunotherapy. This review summarises the recent advances in the prevention, diagnosis and treatment of endometrial cancer and seeks to identify areas for future research.

Schlagwörter

Stichwörter der Autor:innen

advancesdiagnosisendometrial cancerpreventiontreatment

Autor:innen und Institutionen

  • Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.
  • Manchester Academic Health Science Centre, Department of Obstetrics and Gynaecology, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.

ORCID-Profile: Sarah J Kitson

Förderung

  • Cancer Research UK
  • Cancer Grand Challenges

Zitieren

APA

Baker-Rand, H., & Kitson, S. J. (2024). Recent Advances in Endometrial Cancer Prevention, Early Diagnosis and Treatment. Cancers, 16(5), 1028. https://doi.org/10.3390/cancers16051028

Vancouver

Baker-Rand H, Kitson SJ. Recent Advances in Endometrial Cancer Prevention, Early Diagnosis and Treatment. Cancers. 2024;16(5):1028. doi:10.3390/cancers16051028

BibTeX
@article{BakerRand2024,
  author = {Baker-Rand, Holly and Kitson, Sarah J},
  title = {Recent Advances in Endometrial Cancer Prevention, Early Diagnosis and Treatment},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {5},
  pages = {1028},
  doi = {10.3390/cancers16051028}
}
Kostenlos starten →